TrialSignal transduction and targeted therapy2025

Anti-CD38 monoclonal antibody CM313 for systemic lupus erythematosus: a randomized, double-blind, placebo-controlled phase Ib/IIa trial.

Jiuliang Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.